Exagen (XGN)
(Delayed Data from NSDQ)
$9.20 USD
+0.21 (2.34%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $9.18 -0.02 (-0.22%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Exagen Inc. has a market cap of $197.81M, which represents its share price of $8.99 multiplied by its outstanding shares number of 22.00M. As a small-cap company, XGN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
XGN 9.20 +0.21(2.34%)
Will XGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for XGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XGN
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates
Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock?
XGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) Q4 Earnings Top Estimates
Other News for XGN
Exagen (XGN) Receives Price Target Boost as Revenue Outlook Improves
Exagen price target raised by $3 at Cantor Fitzgerald, here's why
Exagen (XGN) Stock Rating Maintained as Canaccord Genuity Raises Price Target | XGN Stock News
What Analysts Are Saying About Exagen Stock
Exagen (XGN) Price Target Raised by Canaccord to $11